Clinical Trials Directory

Trials / Completed

CompletedNCT00629291

MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.

Evaluation of Iron Overload in the Heart, Liver and Pancreas: Patients With Sickle β Thalassemia and Sickle Cell Anemia.

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Sickle cell anemia and Sickle cell β thalassemia patients require multiple transfusions in order to avoid chronic anemia sequel. This regimen entails intrinsic deleterious effects, the majority of which are related to iron deposition in the reticuloendothelial system. Thus, iron is deposited in hepatic, myocardial and endocrine glands tissues. Tools available for iron load evaluation include serum ferrtin levels, liver biopsy and echocardiography, all are non specific. The purpose of this work is to compare iron overload in the liver, heart and pancreas in Sickle cell anemia and Sickle cell β thalassemia patients using T2\* MRI sequences.

Detailed description

Sickle cell anemia and Sickle cell β thalassemia patients recieving multiple transfusions are exposed to the effects of iron deposition in the reticuloendothelial system, including cardiac muscle, liver and pancreas. Tools available for iron load evaluation include serum ferrtin levels, liver biopsy and echocardiography, all are non specific. The purpose of this work is to compare iron overload in the liver, heart and pancreas in Sickle cell anemia and Sickle cell β thalassemia patients using T2\* MRI sequences. Patients and Methods: 27 Sickle cell anemia and 28 Sickle cell β thalassemia will undergo transthoracic echocardiography, cardiac MRI using T2\* sequences and clinical and laboratory evaluation for iron overload including ferritin levels and oral glucose tolerance test .

Conditions

Timeline

Start date
2008-01-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2008-03-05
Last updated
2010-05-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00629291. Inclusion in this directory is not an endorsement.